Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells
- 19 December 2018
- journal article
- research article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 9 (1) , 215-226
Abstract
The article concerns the obtainment of liposomal doxorubicin (Dox) in which liposomes are externally modified with a targeting peptide able to drive the formulation in a selective way on membrane receptors overexpressed in tumors. We developed a kit composed by three different vials: (A) a vial containing a sterile, translucent, red dispersion of the liposomal doxorubicin drug (Doxil®), (B) a vial filled with a lyophilized powder of a modified phospholipid with a reactive function (DSPE-Peg-maleimide), and (C) a vial containing a 1–9 bombesin peptide analogue (Cys-BN-AA1) chemically modified to react in stoichiometric ratio respect to DSPE-Peg-maleimide. The chosen peptide is a stable analogue antagonist of the wild-type 1–9 bombesin peptide; it is very stable in serum; maintains high specificity, with nanomolar affinity, towards gastrin release peptide receptors (GRPRs indicated also as BB2); and is overexpressed in some cancer cells. Results on animal studies clearly indicate that in mice treated with the kit product (i.e., pegylated liposomal Dox modified with the bombesin analogue, Doxil-BN-AA1), tumor growth is reduced, with an improved efficacy respect to mice treated with non-modified pegylated liposomal Dox or with saline solution.Keywords
This publication has 43 references indexed in Scilit:
- Quantitative Evaluation of Bioorthogonal Chemistries for Surface Functionalization of NanoparticlesBioconjugate Chemistry, 2012
- Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and TherapyTheranostics, 2012
- Biology of mammalian bombesin-like peptides and their receptorsCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Peptide modified nanocarriers for selective targeting of bombesin receptorsMolecular BioSystems, 2010
- Algorithm for the Analysis of Tryptophan Fluorescence Spectra and Their Correlation with Protein Structural ParametersAlgorithms, 2009
- High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applicationsEndocrine-Related Cancer, 2009
- Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypesNuclear Medicine and Biology, 2005
- In Vivo Assessment of Antiangiogenic Activity of SU6668 in an Experimental Colon Carcinoma ModelClinical Cancer Research, 2004
- Gastrin-Releasing Peptide Receptors in Non-Neoplastic and Neoplastic Human BreastThe American Journal of Pathology, 1999
- Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networksInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996